Study Stopped
DECISION OF THE COORDINATOR
Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus
PRURINEURO
1 other identifier
observational
40
1 country
1
Brief Summary
Scientific research on pruritus is in intensive development, with significant advances in understanding its pathophysiology. The causes of pruritus are very huge; they can be classified into different categories; we can find dermatological causes, systemic causes, neuropathic or neurological causes, psychogenic or even idiopathic causes. The diagnosis of psychogenic pruritus is often over stated, when no cause is found; therefore, it is important to see what is really relieving from psychic so as not to over-diagnose and adopt a therapy more in line with the real problem of the patient. In daily practice, it seems to have a tendency to separate psychogenic and neurogenic etiologies in the diagnosis of neuropathic or psychogenic pruritus. In the case of patients with psychogenic pruritus and neuropathic pruritus, no study has attempted to study the respective part of psychogenic and neurogenic components. Consequently, it would therefore be interesting to assess the areas of superposition and distinction of neuropathic and psychogenic pruritus. The aim of this pilot study is to assess the psychogenic and neurogenic components of psychogenic pruritus and neuropathic pruritus in order to improve understanding of the mechanism and therefore their management. The main objective of this study is to highlight the differences and the potential common characteristics between psychogenic and neuropathic pruritus in order to improve the differential diagnosis between these two pathologies. The secondary objective of this study is to describe the psychogenic and neurogenic characteristics of psychogenic and neuropathic pruritus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 23, 2021
CompletedStudy Start
First participant enrolled
August 25, 2021
CompletedFirst Posted
Study publicly available on registry
August 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 8, 2022
CompletedJanuary 12, 2024
January 1, 2024
11 months
August 23, 2021
January 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Questionnaire de Brest
Qualitative assessment of pruritus, specifying the chronology, location, intensity, characteristics and effect on daily activities of the itching induced by pruritus
at the enrollment
HADS (Hospital Anxiety and Depression Scale)
Total score for Depression or Anxiety 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case)
at the enrollment
NP5
A score of two criteria out of five is optimal to discriminate Neuropathic pruritus (NP) from Non-NP
at the enrollment
TAS-20
The TAS-20 is a self-report scale that is comprised of 20 items. Items are rated using a 5-point Likert scale whereby 1 = strongly disagree and 5 = strongly agree. There are 5 items that are negatively keyed (items 4, 5, 10, 18 and 19). The total alexithymia score is the sum of responses to all 20 items, while the score for each subscale factor is the sum of the responses to that subscale. The TAS-20 uses cutoff scoring: equal to or less than 51 = non-alexithymia, equal to or greater than 61 = alexithymia. Scores of 52 to 60 = possible alexithymia.
at the enrollment
DN4i
score equal to or greater than 3 : in favor of neuropathic pruritus
at the enrollment
Diagnosis criteria of functional itch disorder or psychogenic pruritus, from the French psychodermatology group
three compulsory criteria; Three additional criteria from seven items should also be present
at the enrollment
Study Arms (2)
Patients with Psychogenic pruritus
Patients with Neuropathic Pruritus
Interventions
Evaluation of the Psychogenic and Neurogenic Components using questionnaires
Eligibility Criteria
Patients with neuropathic or psychogenic pruritus consulting in the dermatology department of the CHRU de Brest.
You may qualify if:
- Major (\> 18 years old)
- Diagnosis of psychogenic pruritus or neuropathic pruritus made in consultation, in day hospital or in hospital, within the dermatology department at the CHRU de Brest
- Able to understand and agree to sign the information and non-opposition notice
- No opposition of the patient
You may not qualify if:
- Patient under legal protection (guardianship, curatorship)
- Minor (\<18 years old)
- Acute or chronic condition which could limit the patient's ability to the study's participation
- Inability to understand and sign the information and non-opposition notice
- Refusal to give no opposition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Brest
Brest, 29609, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2021
First Posted
August 27, 2021
Study Start
August 25, 2021
Primary Completion
July 8, 2022
Study Completion
July 8, 2022
Last Updated
January 12, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will be available beginning two years and ending five years following the publication
- Access Criteria
- Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement.
All collected data that underlie results in a publication